Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Roberta Nicoletti
T-Dm1, a Novel Antibody-Drug Conjugate, Is Highly Effective Against Uterine and Ovarian Carcinosarcomas Overexpressing HER2
Clinical and Experimental Metastasis
Medicine
Cancer Research
Oncology
Related publications
Trastuzumab-Dm1: A Review of the Novel Immuno-Conjugate for HER2- Overexpressing Breast Cancer
The Open Breast Cancer Journal
Resistance to the Antibody–Drug Conjugate T-Dm1 Is Based in a Reduction in Lysosomal Proteolytic Activity
Cancer Research
Cancer Research
Oncology
Antibody–Drug Conjugate Hits Elusive HER2 + Breast Tumors
Cancer Discovery
Oncology
Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas
Balkan Medical Journal
Medicine
T-Dm1 Reduces HER2+ Breast Cancer Recurrence
Cancer Discovery
Oncology
Antibody-Drug Conjugates With HER2-targeting Antibodies From Synthetic Antibody Libraries Are Highly Potent Against HER2-positive Human Gastric Tumor in Xenograft Models
mAbs
Allergy
Immunology
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
Cancer Cell
Cancer Research
Oncology
Cell Biology
Identification of a Novel Topoisomerase Inhibitor Effective in Cells Overexpressing Drug Efflux Transporters
PLoS ONE
Multidisciplinary
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
Cancer Cell
Cancer Research
Oncology
Cell Biology
